Imaging for Target Volume Delineation in Rectal Cancer Radiotherapy - A Systematic Review

被引:26
|
作者
Gwynne, S. [1 ]
Mukherjee, S. [2 ]
Webster, R. [1 ]
Spezi, E. [3 ]
Staffurth, J. [4 ]
Coles, B. [5 ]
Adams, R. [4 ]
机构
[1] Velindre Canc Ctr, Dept Clin Oncol, Cardiff CF14 2TL, S Glam, Wales
[2] Univ Oxford, Gray Inst Radiat Oncol & Biol, Dept Oncol, Oxford OX1 2JD, England
[3] Velindre Canc Ctr, Dept Phys, Cardiff CF14 2TL, S Glam, Wales
[4] Cardiff Univ, Div Canc, Sch Med, Cardiff, S Glam, Wales
[5] Velindre Canc Ctr, Canc Res Wales Lib, Cardiff CF14 2TL, S Glam, Wales
关键词
CT simulation; interobserver variation; MR-CT co-registration; MRI planning; PET/CT; radiotherapy planning; rectal cancer; PREOPERATIVE CONFORMAL RADIOTHERAPY; TOTAL MESORECTAL EXCISION; TUMOR DELINEATION; PET IMAGES; POSTOPERATIVE CHEMORADIOTHERAPY; GUIDED RADIOTHERAPY; RADIATION TREATMENT; TECHNICAL ASPECTS; LOCAL RECURRENCE; LUNG-CANCER;
D O I
10.1016/j.clon.2011.10.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The global move towards more conformal radiotherapy for rectal cancer requires better imaging modalities that both visualise the disease accurately and are reproducible; to reduce interobserver variation. This review explores the advances in imaging modalities used in target volume delineation, with a view to make recommendations for current clinical practice and to propose future directions for research. A systematic review was conducted using MEDLINE and EMBASE. Articles considered relevant by the authors were included. Planning with orthogonal films is being replaced by computed tomography (CT) simulation. This is now considered the 'gold standard' and allows conformal three-dimensional planning. Magnetic resonance imaging (MRI) has been shown to overcome some of the limitations of CT and can be used either as a diagnostic image to visually aid planning, or as a 'planning' MRI carried out in the treatment position and co-registered with the planning CT. The latter approach has been shown to change the treated volumes compared with CT and in prostate cancer patients has been shown to reduce interobserver variation. There are remaining issues with four-dimensional motion that are yet to be fully appreciated or overcome. 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography/CT co-registered with planning CT results in smaller volumes than CT alone and also reduces interobserver variation, but requires further validation before routine implementation. Experimental work utilising novel positron emission tomography tracers and diffusion-weighted MRI shows promise and requires further evaluation. Rigorous quality assurance is important with processing of newer imaging modalities. Further work needs to be conducted into both interobserver variation and the formal evaluation of the clinical benefits of newer imaging modalities. Developments in image-guided radiotherapy are also required to ensure that improvements in target definition at the planning stage are reproducible throughout treatment. (C) 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:52 / 63
页数:12
相关论文
共 50 条
  • [1] FDG-PET/CT and MR imaging for target volume delineation in rectal cancer radiotherapy treatment planning: a systematic review
    Olanloye, Elizabeth E.
    Ramlaul, Aarthi
    Ntekim, Atara, I
    Adeyemi, Segun S.
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2022, 21 (04) : 529 - 539
  • [2] PET imaging for target volume delineation in rectal cancer radiotherapy: results of a phase II study
    Floreno, B.
    Rinaldi, C.
    Fiore, M.
    Trecca, P.
    Greco, C.
    Iurato, A.
    D'Angelillo, R. M.
    Trodella, L.
    Ramella, S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S813 - S813
  • [3] Imaging for Rectal Cancer Radiotherapy - a Systematic Review
    Gwynne, S.
    Webster, R.
    Mukherjee, S.
    Staffurth, J.
    Spezi, E.
    Adams, R.
    CLINICAL ONCOLOGY, 2011, 23 (03) : S37 - S37
  • [4] Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands
    Nijkamp, Jasper
    de Haas-Kock, Danielle F. M.
    Beukema, Jannet C.
    Neelis, Karen J.
    Woutersen, Dankert
    Ceha, Heleen
    Rozema, Tom
    Slot, Annerie
    Vos-Westerman, Hanneke
    Intven, Martijn
    Spruit, Patty H.
    van der Linden, Yvette
    Geijsen, Debby
    Verschueren, Karijn
    van Herk, Marcel B.
    Marijnen, Corrie A. M.
    RADIOTHERAPY AND ONCOLOGY, 2012, 102 (01) : 14 - 21
  • [5] FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer
    Bassi, Maria Chiara
    Turri, Lucia
    Sacchetti, Gianmauro
    Loi, Gianfranco
    Cannillo, Barbara
    La Mattina, Pierdaniele
    Brambilla, Marco
    Inglese, Eugenio
    Krengli, Marco
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (05): : 1423 - 1426
  • [6] Definition and delineation of the clinical target volume for rectal cancer
    Roels, Sarah
    Duthoy, Wim
    Haustermans, Karin
    Penninckx, Freddy
    Vandecaveye, Vincent
    Boterberg, Tom
    De Neve, Wilfried
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (04): : 1129 - 1142
  • [7] Geometrical Analysis of Radiotherapy Target Volume Delineation: a Systematic Review of Reported Comparison Methods
    Hanna, G. G.
    Hounsell, A. R.
    O'Sullivan, J. M.
    CLINICAL ONCOLOGY, 2010, 22 (07) : 515 - 525
  • [8] TARGET VOLUME DELINEATION VARIATION IN PRE-OPERATIVE RADIOTHERAPY OF EARLY-STAGE RECTAL CANCER
    Nijkamp, J.
    de Haas-Kock, D.
    Beukema, J.
    Marijnen, C.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S65 - S65
  • [9] Imaging for Target Delineation in Head and Neck Cancer Radiotherapy
    Jensen, Kenneth
    Al-Farra, Gina
    Dejanovic, Danijela
    Eriksen, Jesper G.
    Loft, Annika
    Hansen, Christian R.
    Pameijer, Frank A.
    Zukauskaite, Ruta
    Grau, Cai
    SEMINARS IN NUCLEAR MEDICINE, 2020, 51 (01) : 59 - 67
  • [10] Advances in automatic delineation of target volume and cardiac substructure in breast cancer radiotherapy (Review)
    Shen, Jingjing
    Gu, Peihua
    Wang, Yun
    Wang, Zhongming
    ONCOLOGY LETTERS, 2023, 25 (03)